Ron Philip, Spark Therapeutics CEO
Roche and bluebird bio settle year-long trademark case, but keep quiet on the details
It appears the sparks flying between Roche and bluebirdbio in a Delaware federal court have fizzled.
Bluebird and Roche’s Spark Therapeutics together filed a motion …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.